The primary objective of this study is to demonstrate the superiority of the CGE physical therapy protocol versus a standard physical therapy protocol of the shoulder by measuring the following after 1 month of physical therapy: the FI2S score including validated measures of pain, glenohumeral joint range of motion in the three planes, the ability to perform certain everyday activities and the strength of forward elevation measured with a dynamometer.
Secondary objectives: * To study the evolution of passive glenohumeral range of motion * To study the evolution of the global range of passive and active motion for each method used * To evaluate functional recovery (DASH) * To evaluate the impact on quality of life (SF36) * To study the difference in visual analog scale scores for pain during physical therapy sessions * Compare the two methods/groups after three months.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
40
Global Shoulder Concept physical therapy sequence for shoulder tendonitis. The procedures used in this protocol refer to physical therapy sequences, not to devices or drugs.
Standard physical therapy sequence for shoulder tendonitis. The procedures used in this protocol refer to physical therapy sequences, not to devices or drugs.
CHU de Montpellier - Hôpital Lapeyronie
Montpellier, France
CHU de Nîmes - Hôpital Universitaire Carémeau
Nîmes, France
change in FI2S score
Time frame: 90 days
Change in visual analog scale for pain
Time frame: Day 1 versus baseline
Change in visual analog scale for pain
Time frame: Day 5 versus baseline
Change in visual analog scale for pain
Time frame: Day 12 versus baseline
Change in visual analog scale for pain
Time frame: Day 19 versus baseline
Change in visual analog scale for pain
Time frame: Day 26 versus baseline
Change in visual analog scale for pain
Time frame: Day 90 versus baseline
Scapulohumeral amplitude gain in 3 main directions
Passive and active mobility are evaluated by manual goniometry.
Time frame: Day 1
Scapulohumeral amplitude gain in 3 main directions
Passive and active mobility are evaluated by manual goniometry.
Time frame: Day 26
Scapulohumeral amplitude gain in 3 main directions
Passive and active mobility are evaluated by manual goniometry.
Time frame: Day 90
Functional gain as measured by the DASH self questionnaire
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: Day 1
Functional gain as measured by the DASH self questionnaire
Time frame: Day 5
Functional gain as measured by the DASH self questionnaire
Time frame: Day 12
Functional gain as measured by the DASH self questionnaire
Time frame: Day 19
Functional gain as measured by the DASH self questionnaire
Time frame: Day 26
Functional gain as measured by the DASH self questionnaire
Time frame: Day 90
FI2S score
Time frame: Day 1
FI2S score
Time frame: Day 5
FI2S score
Time frame: Day 12
FI2S score
Time frame: Day 19
FI2S score
Time frame: Day 26
SF36 self questionnaire
Time frame: Day 1
SF36 self questionnaire
Time frame: Day 26
SF36 self questionnaire
Time frame: Day 90